Item Type | Name |
Academic Article
|
Symptomatic spinal calcinosis in systemic sclerosis (scleroderma).
|
Academic Article
|
Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
|
Academic Article
|
Is occupational organic solvent exposure a risk factor for scleroderma?
|
Academic Article
|
Assessment and management of scleroderma lung disease.
|
Academic Article
|
Solvent oriented hobbies and the risk of systemic sclerosis.
|
Academic Article
|
Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension.
|
Academic Article
|
Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted.
|
Academic Article
|
Cytochrome P2 polymorphisms and susceptibility to scleroderma: comment on the article by Povey et al.
|
Academic Article
|
Clinical aspects of systemic sclerosis (scleroderma).
|
Academic Article
|
Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases.
|
Academic Article
|
Clinical aspects of localized and systemic scleroderma.
|
Academic Article
|
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.
|
Academic Article
|
Assessment of lung involvement.
|
Academic Article
|
Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon.
|
Academic Article
|
Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts.
|
Academic Article
|
Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis.
|
Academic Article
|
Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling.
|
Academic Article
|
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
|
Academic Article
|
Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
|
Academic Article
|
Racial variation in clinical and immunological manifestations of systemic sclerosis.
|
Academic Article
|
Cyclophosphamide versus placebo in scleroderma lung disease.
|
Academic Article
|
Systemic sclerosis: environmental and occupational risk factors.
|
Academic Article
|
Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
|
Academic Article
|
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
|
Academic Article
|
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
|
Academic Article
|
Interstitial lung disease in systemic sclerosis.
|
Academic Article
|
Captive of art, not disease. Paul Klee and his illness, scleroderma.
|
Academic Article
|
Lymphokine activated killer (LAK) cell activity in the peripheral blood lymphocytes of systemic sclerosis (SSc) patients.
|
Academic Article
|
Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.
|
Academic Article
|
Histopathology and bronchoalveolar lavage.
|
Academic Article
|
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
|
Academic Article
|
Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
|
Academic Article
|
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
|
Academic Article
|
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
|
Academic Article
|
Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.
|
Academic Article
|
Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.
|
Academic Article
|
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.
|
Academic Article
|
Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials.
|
Academic Article
|
Coagulation and autoimmunity in scleroderma interstitial lung disease.
|
Academic Article
|
High resolution computed tomography in early scleroderma lung disease.
|
Academic Article
|
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.
|
Academic Article
|
Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
|
Academic Article
|
Racial differences between blacks and whites with systemic sclerosis.
|
Academic Article
|
Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma.
|
Academic Article
|
Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA.
|
Academic Article
|
Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid.
|
Academic Article
|
Anticentromere antibody and immunoglobulin allotypes in scleroderma.
|
Academic Article
|
Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene).
|
Academic Article
|
Failure of the circulatory system limits exercise performance in patients with systemic sclerosis.
|
Academic Article
|
Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy.
|
Academic Article
|
Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
|
Academic Article
|
Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome.
|
Academic Article
|
Paul Klee and scleroderma.
|
Academic Article
|
Scleroderma. Clinical problems. The lungs.
|
Academic Article
|
Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma.
|
Academic Article
|
HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
|
Academic Article
|
Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis.
|
Academic Article
|
Thrombin-mediated cellular events in pulmonary fibrosis associated with systemic sclerosis (scleroderma).
|
Academic Article
|
Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis.
|
Academic Article
|
Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study.
|
Academic Article
|
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
|
Academic Article
|
Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
|
Academic Article
|
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
|
Academic Article
|
New developments in scleroderma interstitial lung disease.
|
Academic Article
|
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
|
Academic Article
|
Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis.
|
Academic Article
|
Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis.
|
Academic Article
|
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.
|
Academic Article
|
Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways.
|
Academic Article
|
Scleroderma following augmentation mammoplasty. Report of a case and review of the literature.
|
Academic Article
|
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.
|
Academic Article
|
Endothelin and scleroderma lung disease.
|
Academic Article
|
Outcome measures in the lung.
|
Academic Article
|
Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.
|
Academic Article
|
Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
|
Academic Article
|
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
|
Academic Article
|
Lung involvement in systemic sclerosis.
|
Academic Article
|
Fibronectin distribution in nailfold biopsies of scleroderma (systemic sclerosis) patients.
|
Academic Article
|
Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease.
|
Academic Article
|
Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
|
Academic Article
|
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.
|
Academic Article
|
Biomarkers of scleroderma lung disease: recent progress.
|
Academic Article
|
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
|
Academic Article
|
Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis.
|
Academic Article
|
Paraspinal tumoral calcinosis in a child with systemic sclerosis/myositis overlap.
|
Academic Article
|
Effect of orofacial exercises on oral aperture in adults with systemic sclerosis.
|
Academic Article
|
A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?
|
Academic Article
|
Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.
|
Academic Article
|
Dipyridamole decreases platelet-derived growth factor levels in human serum.
|
Academic Article
|
Epidermal nuclear immunofluorescence: serological correlations supporting an in vivo reaction.
|
Academic Article
|
Immunofluorescence in skin specimens from three different biopsy sites in patients with scleroderma.
|
Academic Article
|
Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma.
|
Academic Article
|
Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders.
|
Academic Article
|
Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.
|
Academic Article
|
Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor.
|
Academic Article
|
Interstitial lung disease of systemic sclerosis.
|
Academic Article
|
Systemic sclerosis (scleroderma). Clinical management of its major complications.
|
Academic Article
|
Lung disease in systemic sclerosis (scleroderma).
|
Academic Article
|
Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
|
Academic Article
|
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis.
|
Concept
|
Scleroderma, Systemic
|
Academic Article
|
Differential regulation of cell functions by CSD peptide subdomains.
|
Academic Article
|
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
|
Academic Article
|
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
|
Academic Article
|
Systemic sclerosis and the heart.
|
Academic Article
|
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.
|
Academic Article
|
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.
|
Academic Article
|
Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis.
|
Academic Article
|
Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.
|
Academic Article
|
Editorial: molecular insights into systemic sclerosis-associated interstitial lung disease.
|
Academic Article
|
Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.
|
Academic Article
|
Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.
|
Academic Article
|
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.
|
Academic Article
|
Update on scleroderma-associated interstitial lung disease.
|
Academic Article
|
Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative.
|
Academic Article
|
Genetics of systemic sclerosis: recent advances.
|
Academic Article
|
Factors associated with gingival inflammation among adults with systemic sclerosis.
|
Academic Article
|
Factors associated with oral hygiene practices among adults with systemic sclerosis.
|
Academic Article
|
Systemic Sclerosis and Perceptions of Quality in Primary Care.
|
Academic Article
|
Antinuclear antibody-negative systemic sclerosis.
|
Academic Article
|
Management of Systemic-Sclerosis-Associated Interstitial Lung Disease.
|
Academic Article
|
M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo.
|
Academic Article
|
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients.
|
Academic Article
|
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
|
Academic Article
|
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
|
Academic Article
|
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
|
Academic Article
|
Update of EULAR recommendations for the treatment of systemic sclerosis.
|
Academic Article
|
Systemic sclerosis: Choosing patients wisely when treating interstitial lung disease.
|
Academic Article
|
There is a need for new systemic sclerosis subset criteria. A content analytic approach.
|
Academic Article
|
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations.
|
Academic Article
|
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
|
Academic Article
|
Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.
|
Academic Article
|
Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.
|
Academic Article
|
Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic Sclerosis.
|
Academic Article
|
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.
|
Academic Article
|
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.
|
Academic Article
|
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.
|
Academic Article
|
Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease.
|
Academic Article
|
HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.
|
Academic Article
|
Systemic sclerosis-associated interstitial lung disease.
|
Academic Article
|
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
|
Academic Article
|
Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis.
|
Academic Article
|
Associations Between Patterns of Esophageal Dysmotility and Extra-Intestinal Features in Patients With Systemic Sclerosis.
|